News

Big news! Our co-founder & CSO Ian Soulairol has just received the “Coup de Cœur” award from Montpellier Méditerranée Métropole at the 2026 Innovation Awards

With 7 days to go until VivaTech 2026, discover how MB Therapeutics is revolutionizing precision pharmaceutics through 3D-printed medicines.

Discover our medical 3D printing solutions and meet with our experts to discuss the future of pharmacy.

Discover how medical 3D printing is being integrated at the CHU d’Angers. Expert support, commissioning, and the challenges of tomorrow’s medicine.

A look back at the visit of a delegation from Saxony to MB Therapeutics. A moment of exchange to showcase our pharmaceutical expertise to our German partners.

Discover how MB Therapeutics integrates CSR into every strategic decision, from 3D drug printing to sustainable office management.

Discover 3D printing of medications and how it is transforming pharmaceutical production, particularly with 3DforPedia.

Focus on 3D printing: MB Therapeutics welcomes long-standing partners University of Montpellier, Nîmes University Hospital, and the Occitanie Region.

€500,000 to industrialize our pharmaceutical inks and equip the first pilot pharmacies by 2026. Discover how this strategic support will accelerate our deployment.

Meet our Chief Business Officer, appointed to accelerate our commercial development and expand our model internationally.